In a promising development for cancer treatment, a collaborative research team has overcome two issues that have prevented ...

SCN2A‑related developmental epileptic encephalopathy (DEE) is a rare, severe form of childhood epilepsy and one of the most ...

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

Understand the difference between targeted therapy, chemotherapy, and immunotherapy in lung cancer — and why starting the wrong treatment first can be harmful for patients with targetable mutations.

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to buy right now. An expanding radiopharmaceutical pipeline, ...

AstraZeneca (AZN) has reached a partnership worth up to $1.77B with CSPC ‌Pharmaceutical Group (CSPCY) to develop and commercialize treatments for kidney diseases, Reuters reported on Thursday, based ...

Former Transportation Secretary Pete Buttigieg said Friday that he and his family in Michigan were targeted by a “false report” to state authorities claiming he was a danger to his 4-year-old twins.

Neuroendocrine neoplasms are a heterogeneous group of malignancies ranging from indolent well-differentiated neuroendocrine tumors (NETs) to aggressive poorly differentiated neuroendocrine carcinomas ...

Please provide your email address to receive an email when new articles are posted on . Therapies in development to lower lipoprotein(a) act by targeting apolipoprotein A to limit Lp(a) production. A ...